Skip to main content
search

Healthy, Drug-Resistant Microglia Reinvigorate Mouse Brain

By January 9, 2023Carousel Slider, In the News

Only Mutants. While wild-type human microglia perished in mice after two months of CSF1R inhibitor treatment (left), G795A microglia expanded to fill the entire brain (green, right). [Courtesy of Chadarevian et al., Journal of Experimental Medicine, 2022.]

UCI MIND faculty member and professor, Mathew Blurton-Jones, PhD, is featured in AlzForum for his lab’s recent collaborative work on creating a new strain of resistant microglia. Lead author and graduate student in the Blurton-Jones lab, Jean Paul Chadarevian, along with collaborators at the University of Pennsylvania published their innovative work in Journal of Experimental Medicine in the December 2022 issue.

Related posts:

  1. Dr. Craig Stark takes UCI’s women’s health research to new heights with the Ann S. Bowers Women’s Brain Health Initiative As we celebrate Women’s History Month this March, we also find ourselves at a historic moment in scientific inquiry for women’s health research. Today, nearly two-thirds of Americans with Alzheimer’s disease are women, but the underlying cause of this sex disparity is still poorly understood. For decades, research focusing on...
  2. LA Times article highlights ARIA A June 17 article in the Los Angeles Times highlighted an important safety risk associated with the new class of medications recently approved for treating Alzheimer’s disease. The drugs are anti-amyloid monoclonal antibodies and include aducanumab, donanemab, and lecanemab. Of these, only lecanemab has achieved full FDA approval at the...
Close Menu